Patent · US Active

Uracil derivatives as AXL and c-MET kinase inhibitors

US10017496B2 · kind B2 · utility

0Cited by
3References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2017
Grant dateJul 10, 2018
Priority date—
Expiry dateJul 13, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/056
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein Ra, Rb, Rc, Rd, D, W, R1a, R1b, R1c, Y, R3, X, E and G are as defined herein, methods of treatment and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.